Potent Antiplatelet Therapy May Reduce Death from Sepsis in Patients on Chronic Dialysis

Am J Cardiol. 2022 Jan 1;162:209-211. doi: 10.1016/j.amjcard.2021.10.001. Epub 2021 Nov 3.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / mortality
  • Kidney Failure, Chronic / therapy*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prasugrel Hydrochloride / therapeutic use
  • Purinergic P2Y Receptor Antagonists / therapeutic use*
  • Renal Dialysis*
  • Sepsis / mortality*
  • Sepsis / prevention & control*
  • Ticagrelor / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Prasugrel Hydrochloride
  • Ticagrelor